WWTR1 and glioblastoma: Recently, Escoll et al. showed that NRF2 (Nuclear factor (erythroid-derived 2)-like 2) transcription factor related to cellular defense against oxidative stress was involved in tumor progression by providing metabolic adaptation to tumorigenic demands and resistance to chemotherapeutics and that it induces TAZ expression promoting tumorigenesis in GBM [77].